nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Dermatitis—Ifosfamide—testicular cancer	0.000499	0.000499	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Methotrexate—testicular cancer	0.000499	0.000499	CcSEcCtD
Dexmethylphenidate—Urticaria—Etoposide—testicular cancer	0.000497	0.000497	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Epirubicin—testicular cancer	0.000496	0.000496	CcSEcCtD
Dexmethylphenidate—Rhinitis—Epirubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Etoposide—testicular cancer	0.000495	0.000495	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Etoposide—testicular cancer	0.000495	0.000495	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Doxorubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Epirubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Dexmethylphenidate—Eye disorder—Methotrexate—testicular cancer	0.000493	0.000493	CcSEcCtD
Dexmethylphenidate—Asthenia—Cisplatin—testicular cancer	0.00049	0.00049	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Epirubicin—testicular cancer	0.00049	0.00049	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Methotrexate—testicular cancer	0.00049	0.00049	CcSEcCtD
Dexmethylphenidate—Sweating—Doxorubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Epirubicin—testicular cancer	0.000488	0.000488	CcSEcCtD
Dexmethylphenidate—Haematuria—Doxorubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000481	0.000481	CcSEcCtD
Dexmethylphenidate—Epistaxis—Doxorubicin—testicular cancer	0.00048	0.00048	CcSEcCtD
Dexmethylphenidate—Angiopathy—Methotrexate—testicular cancer	0.000479	0.000479	CcSEcCtD
Dexmethylphenidate—Sinusitis—Doxorubicin—testicular cancer	0.000478	0.000478	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Methotrexate—testicular cancer	0.000477	0.000477	CcSEcCtD
Dexmethylphenidate—Visual impairment—Epirubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Methotrexate—testicular cancer	0.000476	0.000476	CcSEcCtD
Dexmethylphenidate—Chills—Methotrexate—testicular cancer	0.000474	0.000474	CcSEcCtD
Dexmethylphenidate—Nausea—Ifosfamide—testicular cancer	0.000471	0.000471	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Cisplatin—testicular cancer	0.000468	0.000468	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Epirubicin—testicular cancer	0.000467	0.000467	CcSEcCtD
Dexmethylphenidate—Alopecia—Methotrexate—testicular cancer	0.000466	0.000466	CcSEcCtD
Dexmethylphenidate—Bradycardia—Doxorubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Dexmethylphenidate—Mental disorder—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Dexmethylphenidate—Eye disorder—Epirubicin—testicular cancer	0.000462	0.000462	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Etoposide—testicular cancer	0.000461	0.000461	CcSEcCtD
Dexmethylphenidate—Erythema—Methotrexate—testicular cancer	0.000459	0.000459	CcSEcCtD
Dexmethylphenidate—Malnutrition—Methotrexate—testicular cancer	0.000459	0.000459	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Doxorubicin—testicular cancer	0.000459	0.000459	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Epirubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Flushing—Epirubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Rhinitis—Doxorubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Doxorubicin—testicular cancer	0.000457	0.000457	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Doxorubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Doxorubicin—testicular cancer	0.000451	0.000451	CcSEcCtD
Dexmethylphenidate—Asthenia—Etoposide—testicular cancer	0.000449	0.000449	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Dexmethylphenidate—Angiopathy—Epirubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Epirubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Dexmethylphenidate—Back pain—Methotrexate—testicular cancer	0.000444	0.000444	CcSEcCtD
Dexmethylphenidate—Chills—Epirubicin—testicular cancer	0.000443	0.000443	CcSEcCtD
Dexmethylphenidate—Pruritus—Etoposide—testicular cancer	0.000443	0.000443	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Epirubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Dexmethylphenidate—Visual impairment—Doxorubicin—testicular cancer	0.00044	0.00044	CcSEcCtD
Dexmethylphenidate—Alopecia—Epirubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Dexmethylphenidate—Vomiting—Cisplatin—testicular cancer	0.000434	0.000434	CcSEcCtD
Dexmethylphenidate—Vision blurred—Methotrexate—testicular cancer	0.000433	0.000433	CcSEcCtD
Dexmethylphenidate—Mental disorder—Epirubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Doxorubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Dexmethylphenidate—Rash—Cisplatin—testicular cancer	0.000431	0.000431	CcSEcCtD
Dexmethylphenidate—Dermatitis—Cisplatin—testicular cancer	0.00043	0.00043	CcSEcCtD
Dexmethylphenidate—Malnutrition—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Dexmethylphenidate—Erythema—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Etoposide—testicular cancer	0.000428	0.000428	CcSEcCtD
Dexmethylphenidate—Eye disorder—Doxorubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Methotrexate—testicular cancer	0.000426	0.000426	CcSEcCtD
Dexmethylphenidate—Anaemia—Methotrexate—testicular cancer	0.000425	0.000425	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—testicular cancer	0.000424	0.000424	CcSEcCtD
Dexmethylphenidate—Tension—Epirubicin—testicular cancer	0.000422	0.000422	CcSEcCtD
Dexmethylphenidate—Nervousness—Epirubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
Dexmethylphenidate—Back pain—Epirubicin—testicular cancer	0.000416	0.000416	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—testicular cancer	0.000415	0.000415	CcSEcCtD
Dexmethylphenidate—Malaise—Methotrexate—testicular cancer	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Dizziness—Etoposide—testicular cancer	0.000414	0.000414	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Epirubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Dexmethylphenidate—Vertigo—Methotrexate—testicular cancer	0.000413	0.000413	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000412	0.000412	CcSEcCtD
Dexmethylphenidate—Leukopenia—Methotrexate—testicular cancer	0.000411	0.000411	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—testicular cancer	0.00041	0.00041	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Dexmethylphenidate—Nausea—Cisplatin—testicular cancer	0.000406	0.000406	CcSEcCtD
Dexmethylphenidate—Vision blurred—Epirubicin—testicular cancer	0.000405	0.000405	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—testicular cancer	0.000404	0.000404	CcSEcCtD
Dexmethylphenidate—Cough—Methotrexate—testicular cancer	0.000401	0.000401	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Epirubicin—testicular cancer	0.000399	0.000399	CcSEcCtD
Dexmethylphenidate—Convulsion—Methotrexate—testicular cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Vomiting—Etoposide—testicular cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Dexmethylphenidate—Anaemia—Epirubicin—testicular cancer	0.000397	0.000397	CcSEcCtD
Dexmethylphenidate—Agitation—Epirubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Dexmethylphenidate—Rash—Etoposide—testicular cancer	0.000395	0.000395	CcSEcCtD
Dexmethylphenidate—Dermatitis—Etoposide—testicular cancer	0.000394	0.000394	CcSEcCtD
Dexmethylphenidate—Headache—Etoposide—testicular cancer	0.000392	0.000392	CcSEcCtD
Dexmethylphenidate—Arthralgia—Methotrexate—testicular cancer	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Chest pain—Methotrexate—testicular cancer	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Myalgia—Methotrexate—testicular cancer	0.000391	0.000391	CcSEcCtD
Dexmethylphenidate—Tension—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000388	0.000388	CcSEcCtD
Dexmethylphenidate—Malaise—Epirubicin—testicular cancer	0.000388	0.000388	CcSEcCtD
Dexmethylphenidate—Discomfort—Methotrexate—testicular cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Vertigo—Epirubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Syncope—Epirubicin—testicular cancer	0.000386	0.000386	CcSEcCtD
Dexmethylphenidate—Leukopenia—Epirubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—testicular cancer	0.000382	0.000382	CcSEcCtD
Dexmethylphenidate—Palpitations—Epirubicin—testicular cancer	0.00038	0.00038	CcSEcCtD
Dexmethylphenidate—Confusional state—Methotrexate—testicular cancer	0.000378	0.000378	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Epirubicin—testicular cancer	0.000378	0.000378	CcSEcCtD
Dexmethylphenidate—Cough—Epirubicin—testicular cancer	0.000375	0.000375	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Methotrexate—testicular cancer	0.000375	0.000375	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—testicular cancer	0.000375	0.000375	CcSEcCtD
Dexmethylphenidate—Convulsion—Epirubicin—testicular cancer	0.000373	0.000373	CcSEcCtD
Dexmethylphenidate—Infection—Methotrexate—testicular cancer	0.000373	0.000373	CcSEcCtD
Dexmethylphenidate—Nausea—Etoposide—testicular cancer	0.000372	0.000372	CcSEcCtD
Dexmethylphenidate—Hypertension—Epirubicin—testicular cancer	0.000371	0.000371	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Methotrexate—testicular cancer	0.000368	0.000368	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—testicular cancer	0.000368	0.000368	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Methotrexate—testicular cancer	0.000367	0.000367	CcSEcCtD
Dexmethylphenidate—Arthralgia—Epirubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Myalgia—Epirubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Chest pain—Epirubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—testicular cancer	0.000366	0.000366	CcSEcCtD
Dexmethylphenidate—Anxiety—Epirubicin—testicular cancer	0.000365	0.000365	CcSEcCtD
Dexmethylphenidate—Skin disorder—Methotrexate—testicular cancer	0.000364	0.000364	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000364	0.000364	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Methotrexate—testicular cancer	0.000362	0.000362	CcSEcCtD
Dexmethylphenidate—Discomfort—Epirubicin—testicular cancer	0.000362	0.000362	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—testicular cancer	0.000359	0.000359	CcSEcCtD
Dexmethylphenidate—Dry mouth—Epirubicin—testicular cancer	0.000358	0.000358	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Dexmethylphenidate—Anorexia—Methotrexate—testicular cancer	0.000357	0.000357	CcSEcCtD
Dexmethylphenidate—Syncope—Doxorubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Dexmethylphenidate—Confusional state—Epirubicin—testicular cancer	0.000354	0.000354	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—testicular cancer	0.000352	0.000352	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Epirubicin—testicular cancer	0.000351	0.000351	CcSEcCtD
Dexmethylphenidate—Oedema—Epirubicin—testicular cancer	0.000351	0.000351	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—testicular cancer	0.00035	0.00035	CcSEcCtD
Dexmethylphenidate—Infection—Epirubicin—testicular cancer	0.000349	0.000349	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—testicular cancer	0.000347	0.000347	CcSEcCtD
Dexmethylphenidate—Shock—Epirubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—testicular cancer	0.000345	0.000345	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Epirubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Epirubicin—testicular cancer	0.000344	0.000344	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—testicular cancer	0.000343	0.000343	CcSEcCtD
Dexmethylphenidate—Tachycardia—Epirubicin—testicular cancer	0.000342	0.000342	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000342	0.000342	CcSEcCtD
Dexmethylphenidate—Skin disorder—Epirubicin—testicular cancer	0.000341	0.000341	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Epirubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Insomnia—Methotrexate—testicular cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—testicular cancer	0.000339	0.000339	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—testicular cancer	0.000338	0.000338	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Methotrexate—testicular cancer	0.000337	0.000337	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000336	0.000336	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—testicular cancer	0.000335	0.000335	CcSEcCtD
Dexmethylphenidate—Anorexia—Epirubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Methotrexate—testicular cancer	0.000334	0.000334	CcSEcCtD
Dexmethylphenidate—Somnolence—Methotrexate—testicular cancer	0.000333	0.000333	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—testicular cancer	0.000331	0.000331	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Methotrexate—testicular cancer	0.00033	0.00033	CcSEcCtD
Dexmethylphenidate—Confusional state—Doxorubicin—testicular cancer	0.000327	0.000327	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Methotrexate—testicular cancer	0.000326	0.000326	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000325	0.000325	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—testicular cancer	0.000325	0.000325	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000324	0.000324	CcSEcCtD
Dexmethylphenidate—Fatigue—Methotrexate—testicular cancer	0.000323	0.000323	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—testicular cancer	0.000323	0.000323	CcSEcCtD
Dexmethylphenidate—Pain—Methotrexate—testicular cancer	0.000321	0.000321	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00032	0.00032	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—testicular cancer	0.000319	0.000319	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000318	0.000318	CcSEcCtD
Dexmethylphenidate—Insomnia—Epirubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—testicular cancer	0.000315	0.000315	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Epirubicin—testicular cancer	0.000315	0.000315	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—testicular cancer	0.000314	0.000314	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Epirubicin—testicular cancer	0.000313	0.000313	CcSEcCtD
Dexmethylphenidate—Somnolence—Epirubicin—testicular cancer	0.000312	0.000312	CcSEcCtD
Dexmethylphenidate—Anorexia—Doxorubicin—testicular cancer	0.00031	0.00031	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Methotrexate—testicular cancer	0.000309	0.000309	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Epirubicin—testicular cancer	0.000309	0.000309	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000307	0.000307	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Epirubicin—testicular cancer	0.000305	0.000305	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000303	0.000303	CcSEcCtD
Dexmethylphenidate—Fatigue—Epirubicin—testicular cancer	0.000303	0.000303	CcSEcCtD
Dexmethylphenidate—Pain—Epirubicin—testicular cancer	0.0003	0.0003	CcSEcCtD
Dexmethylphenidate—Constipation—Epirubicin—testicular cancer	0.0003	0.0003	CcSEcCtD
Dexmethylphenidate—Urticaria—Methotrexate—testicular cancer	0.000298	0.000298	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Methotrexate—testicular cancer	0.000296	0.000296	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Methotrexate—testicular cancer	0.000296	0.000296	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—testicular cancer	0.000294	0.000294	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Doxorubicin—testicular cancer	0.000292	0.000292	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Epirubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000287	0.000287	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Doxorubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—testicular cancer	0.000282	0.000282	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00028	0.00028	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—testicular cancer	0.00028	0.00028	CcSEcCtD
Dexmethylphenidate—Urticaria—Epirubicin—testicular cancer	0.000279	0.000279	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—testicular cancer	0.000278	0.000278	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—testicular cancer	0.000278	0.000278	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Epirubicin—testicular cancer	0.000277	0.000277	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Epirubicin—testicular cancer	0.000277	0.000277	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Methotrexate—testicular cancer	0.000276	0.000276	CcSEcCtD
Dexmethylphenidate—Asthenia—Methotrexate—testicular cancer	0.000269	0.000269	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—testicular cancer	0.000268	0.000268	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000266	0.000266	CcSEcCtD
Dexmethylphenidate—Pruritus—Methotrexate—testicular cancer	0.000265	0.000265	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Epirubicin—testicular cancer	0.000259	0.000259	CcSEcCtD
Dexmethylphenidate—Urticaria—Doxorubicin—testicular cancer	0.000258	0.000258	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—testicular cancer	0.000257	0.000257	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—testicular cancer	0.000257	0.000257	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Methotrexate—testicular cancer	0.000257	0.000257	CcSEcCtD
Dexmethylphenidate—Asthenia—Epirubicin—testicular cancer	0.000252	0.000252	CcSEcCtD
Dexmethylphenidate—Pruritus—Epirubicin—testicular cancer	0.000248	0.000248	CcSEcCtD
Dexmethylphenidate—Dizziness—Methotrexate—testicular cancer	0.000248	0.000248	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Epirubicin—testicular cancer	0.00024	0.00024	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—testicular cancer	0.000239	0.000239	CcSEcCtD
Dexmethylphenidate—Vomiting—Methotrexate—testicular cancer	0.000238	0.000238	CcSEcCtD
Dexmethylphenidate—Rash—Methotrexate—testicular cancer	0.000236	0.000236	CcSEcCtD
Dexmethylphenidate—Dermatitis—Methotrexate—testicular cancer	0.000236	0.000236	CcSEcCtD
Dexmethylphenidate—Headache—Methotrexate—testicular cancer	0.000235	0.000235	CcSEcCtD
Dexmethylphenidate—Asthenia—Doxorubicin—testicular cancer	0.000233	0.000233	CcSEcCtD
Dexmethylphenidate—Dizziness—Epirubicin—testicular cancer	0.000232	0.000232	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—testicular cancer	0.00023	0.00023	CcSEcCtD
Dexmethylphenidate—Vomiting—Epirubicin—testicular cancer	0.000223	0.000223	CcSEcCtD
Dexmethylphenidate—Nausea—Methotrexate—testicular cancer	0.000223	0.000223	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Doxorubicin—testicular cancer	0.000222	0.000222	CcSEcCtD
Dexmethylphenidate—Rash—Epirubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
Dexmethylphenidate—Dermatitis—Epirubicin—testicular cancer	0.000221	0.000221	CcSEcCtD
Dexmethylphenidate—Headache—Epirubicin—testicular cancer	0.00022	0.00022	CcSEcCtD
Dexmethylphenidate—Dizziness—Doxorubicin—testicular cancer	0.000215	0.000215	CcSEcCtD
Dexmethylphenidate—Nausea—Epirubicin—testicular cancer	0.000208	0.000208	CcSEcCtD
Dexmethylphenidate—Vomiting—Doxorubicin—testicular cancer	0.000206	0.000206	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—testicular cancer	0.000205	0.000205	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—testicular cancer	0.000205	0.000205	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—testicular cancer	0.000203	0.000203	CcSEcCtD
Dexmethylphenidate—Nausea—Doxorubicin—testicular cancer	0.000193	0.000193	CcSEcCtD
